Pandemic Windfall Upends Status Quo For Top-10 Best-Selling Drugs

This article reveals the top 10 pharmaceutical products by revenues in 2022 and discusses the major themes affecting the highest-grossing drugs and the companies behind their continued development.    

vaccination
• Source: Shutterstock

Now that the books for 2021 are closed, In Vivo has crunched the numbers and can report on the best-selling pharmaceuticals last year. And what a year it was, with expectations for drug launches having been completely rewritten. Humira lost its record for peak annual drug sales, not to Keytruda as had seemed inevitable for the past couple of years, but to a product that transitioned from bench to bedside to $40bn+ dollars in under two years.

Pfizer Inc.’s Comirnaty, licensed from BioNTech SE, along with Moderna, Inc.’s mRNA COVID-19 vaccine Spikevax, capitalized on...

More from Growth

More from In Vivo